• LAST PRICE
    12.5200
  • TODAY'S CHANGE (%)
    Trending Down-0.1800 (-1.4173%)
  • Bid / Lots
    5.0600/ 2
  • Ask / Lots
    14.9000/ 1
  • Open / Previous Close
    12.6500 / 12.7000
  • Day Range
    Low 12.4800
    High 13.0500
  • 52 Week Range
    Low 6.1200
    High 16.9050
  • Volume
    101,893
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 12.7
TimeVolumeMLYS
09:32 ET46212.695
09:35 ET27012.55
09:44 ET22712.51
09:48 ET21612.59
09:51 ET105312.59
09:53 ET20012.67
09:55 ET10012.66
10:00 ET20012.64
10:02 ET10012.65
10:06 ET10012.65
10:08 ET140412.66
10:09 ET10012.74
10:11 ET10012.73
10:13 ET33612.675
10:15 ET58012.675
10:18 ET10012.73
10:20 ET10012.675
10:22 ET10012.67
10:24 ET150612.62
10:33 ET17512.554
10:38 ET10012.64
10:40 ET10012.65
10:42 ET20012.595
10:44 ET10012.64
10:45 ET10012.65
10:47 ET10012.72
10:49 ET10012.72
10:51 ET10012.71
10:56 ET10012.71
10:58 ET40012.73
11:00 ET30012.76
11:02 ET10012.76
11:03 ET30012.82
11:12 ET10012.81
11:14 ET77812.67
11:16 ET37912.66
11:25 ET43012.71
11:27 ET10012.79
11:32 ET10012.87
11:38 ET113712.77
11:39 ET10012.86
11:50 ET10012.96
11:57 ET30012.91
12:08 ET10013.01
12:15 ET10013.01
12:21 ET10013.01
12:24 ET20013.04
12:26 ET10013.04
12:32 ET10013.05
12:35 ET10013.05
12:37 ET10013.05
12:39 ET110012.975
12:44 ET10012.98
12:48 ET20012.93
12:51 ET10012.95
12:53 ET10012.99
12:55 ET20012.95
01:02 ET10012.98
01:04 ET129712.895
01:08 ET12012.86
01:11 ET139012.854
01:20 ET11412.845
01:24 ET10012.89
01:26 ET60012.88
01:27 ET10012.96
01:31 ET10012.96
01:33 ET10012.92
01:36 ET10012.88
01:38 ET128812.785
01:40 ET10012.72
01:42 ET10012.75
01:45 ET112112.77
01:54 ET20012.81
01:56 ET10012.9
02:16 ET71612.795
02:18 ET28412.75
02:20 ET10012.73
02:25 ET60012.75
02:27 ET20012.73
02:34 ET60012.81
02:38 ET10012.775
02:39 ET20012.73
02:41 ET55212.69
02:52 ET120012.79
02:56 ET10012.78
02:57 ET10012.79
02:59 ET60012.73
03:01 ET86112.705
03:12 ET20012.76
03:14 ET30012.78
03:15 ET20012.79
03:17 ET10012.81
03:21 ET140012.71
03:26 ET10012.76
03:30 ET20012.74
03:33 ET10012.775
03:35 ET20012.78
03:37 ET10012.78
03:39 ET139212.705
03:42 ET30012.71
03:46 ET12912.705
03:48 ET180012.61
03:50 ET573712.48
03:51 ET110012.66
03:53 ET170012.59
03:55 ET191512.59
03:57 ET233912.54
04:00 ET2020012.52
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMLYS
Mineralys Therapeutics Inc
621.6M
-3.8x
---
United StatesMBX
MBX Biosciences Inc
618.2M
0.0x
---
United StatesALT
Altimmune Inc
617.4M
-5.4x
---
United StatesOMER
Omeros Corp
632.2M
-3.9x
---
United StatesTRML
Tourmaline Bio Inc
590.0M
-14.2x
---
United StatesSANA
Sana Biotechnology Inc
582.7M
-1.7x
---
As of 2024-11-26

Company Information

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone. The Company’s product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) that the Company is initially developing for the treatment of patients with uncontrolled hypertension (uHTN). Lorundrostat is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone. The Company completed the Target-HTN trial, a Phase II proof-of-concept trial for lorundrostat in the treatment of uHTN. In addition to hypertension, the Company intends to develop lorundrostat for the treatment of chronic kidney disease (CKD).

Contact Information

Headquarters
150 N. Radnor Chester Road, Suite F200RADNOR, PA, United States 19087
Phone
302-658-7581
Fax
302-655-5049

Executives

Executive Chairman of the Board, Founder
Brian Slingsby
Chief Executive Officer, Director
Jon Congleton
Chief Financial Officer, Company Secretary
Adam Levy
Chief Medical Officer
David Rodman
Chief Business Officer
Minji Kim

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$621.6M
Revenue (TTM)
$0.00
Shares Outstanding
49.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.27
Book Value
$5.86
P/E Ratio
-3.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.